全文获取类型
收费全文 | 2464篇 |
免费 | 90篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 63篇 |
妇产科学 | 15篇 |
基础医学 | 134篇 |
口腔科学 | 2篇 |
临床医学 | 208篇 |
内科学 | 1050篇 |
神经病学 | 22篇 |
特种医学 | 46篇 |
外科学 | 84篇 |
综合类 | 452篇 |
预防医学 | 66篇 |
眼科学 | 1篇 |
药学 | 302篇 |
7篇 | |
中国医学 | 118篇 |
肿瘤学 | 12篇 |
出版年
2023年 | 30篇 |
2022年 | 52篇 |
2021年 | 63篇 |
2020年 | 67篇 |
2019年 | 45篇 |
2018年 | 67篇 |
2017年 | 37篇 |
2016年 | 57篇 |
2015年 | 58篇 |
2014年 | 174篇 |
2013年 | 132篇 |
2012年 | 135篇 |
2011年 | 169篇 |
2010年 | 136篇 |
2009年 | 126篇 |
2008年 | 160篇 |
2007年 | 141篇 |
2006年 | 147篇 |
2005年 | 117篇 |
2004年 | 98篇 |
2003年 | 85篇 |
2002年 | 67篇 |
2001年 | 53篇 |
2000年 | 51篇 |
1999年 | 41篇 |
1998年 | 20篇 |
1997年 | 25篇 |
1996年 | 22篇 |
1995年 | 26篇 |
1994年 | 20篇 |
1993年 | 25篇 |
1992年 | 20篇 |
1991年 | 18篇 |
1990年 | 18篇 |
1989年 | 6篇 |
1988年 | 9篇 |
1987年 | 12篇 |
1986年 | 6篇 |
1985年 | 12篇 |
1984年 | 11篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1981年 | 5篇 |
1977年 | 2篇 |
1976年 | 3篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1969年 | 2篇 |
排序方式: 共有2585条查询结果,搜索用时 94 毫秒
1.
2.
We describe a case of undiagnosed heart block which was detected during the postpartum surgical repair of a vaginal tear, and the subsequent investigations that confirmed diagnosis of atrio-ventricular heart block. 相似文献
3.
静脉注射胺碘酮治疗快速心房纤颤的临床观察 总被引:2,自引:1,他引:1
目的:观察静脉注射胺碘酮对心房纤颤并快速心室率(简称快速型房颤)患者的临床疗效。方法:对34例新发快速型房颤患者,10 min静脉推注胺碘酮150 mg,观察10 min,未转为窦性心律者再次于10 min内推注150 mg,仍未转复者则以0.5~1.0 mg/min静脉滴注24 h,转为窦性心律者则随时终止滴注。观察房颤转复、心室率控制情况及不良反应,同时比较老年组(18例)和非老年组(16例)有何不同。结果:34例患者在24 h内均转为窦性心律。两组患者用药后30 min,1 h,6 h,24 h心室率分别为(96.00±8.39)次/min与(98.00±8.35)次/min,(88.13±9.98)次/min与(86.47±8.68)次/min,(84.88±10.19)次/min与(82.88±8.25)次/min,(74.88±9.80)次/min与(78.88±7.80)次/min,较用药前的(138.58±9.15)次/min与(130.36±8.26)次/min明显下降(P<0.01),但两组间用药前、后无显著差异。无严重心律失常发生,未诱发或加重心功能不全。结论:静脉应用胺碘酮治疗快速型房颤安全有效,老年人用药剂量不减。 相似文献
4.
眼针治疗阵发性室上性心动过速120例的即时疗效观察 总被引:2,自引:0,他引:2
目的:观察眼针对阵发性室上性心动过速的即时疗效。方法:选择符合诊断标准的门诊患者120例,针其眼针穴区:心区和上焦区。针后30分钟描记心电图,计算心率,观察眼针对阵发性室上性心动过速的影响。结果:显效103例,占85.83%;有效9例,占7.5%;无效8例,占6.66%;总有效率93.33%.结论:眼针对阵发性室上性心动过速有较好的即时疗效。 相似文献
5.
aVR sign as a risk factor for life-threatening arrhythmic events in patients with Brugada syndrome 总被引:2,自引:0,他引:2
BACKGROUND: Risk stratification in Brugada syndrome (BS) is controversial, especially in asymptomatic individuals. OBJECTIVE: The aim of this study was to evaluate the significance of lead aVR in patients with BS. METHODS: Twenty-four patients with the electrocardiogram pattern of BS (24 male, mean age 32.1 +/- 13.6 years) and 24 healthy age- and gender-matched controls were studied. RESULTS: Thirteen patients were symptomatic. The R-wave amplitude or R/q ratio in lead aVR was significantly greater in patients experiencing a recurrence compared with those who did not. The aVR sign was defined as R wave >/= 0.3 mV or R/q >/= 0.75 in lead aVR. Most of the recurrences (78%) were in patients with present aVR sign; 84% of BS patients with present aVR sign had events during follow-up. In contrast, only 27% of BS patients with absent aVR sign had events during follow-up. CONCLUSION: Our study shows significant correlation between a prominent R wave in lead aVR (aVR sign) and risk for development of arrhythmic events in BS. In the presence of BS, prominent R wave in lead aVR may reflect more right ventricular conduction delay and subsequently more electrical heterogeneity, which in turn is responsible for a higher risk of arrhythmia. 相似文献
6.
目前,可插入式循环心律监测仪是一个高诊断率且寿命较长的皮下无电极心律监测仪.它可提供边续14个月的监测,由此大增加了捕获有显著症状的心律失常的机会. 相似文献
7.
Jere Paavola Matti Viitasalo P?ivi J Laitinen-Forsblom Michael Pasternack Heikki Swan Ilkka Tikkanen Lauri Toivonen Kimmo Kontula Mika Laine 《European heart journal》2007,28(9):1135-1142
AIMS: Mutations in cardiac ryanodine receptors (RyR2s) are linked to catecholaminergic polymorphic ventricular tachycardia (CPVT), characterized by risk of polymorphic ventricular tachyarrhythmias and sudden death during exercise. Arrhythmias are caused by gain-of-function defects in RyR2, but cellular arrhythmogenesis remains elusive. METHODS AND RESULTS: We recorded endocardial monophasic action potentials (MAPs) at right ventricular septum in 15 CPVT patients with a RyR2 mutation (P2,328S, Q4,201R, and V4,653F) and in 12 control subjects both at baseline and during epinephrine infusion (0.05 microg/kg/min). At baseline 3 and during epinephrine infusion, four CPVT patients, but none of the control subjects, showed delayed afterdepolarizations (DADs) occasionally coinciding with ventricular premature complexes. In order to study the underlying mechanisms, we expressed two types of mutant RyR2 (P2,328S and V4,653F) causing CPVT as well as wild-type RyR2 in HEK 293 cells. Confocal microscopy of Fluo-3 loaded cells transfected with any of the three RyR2s showed no spontaneous subcellular Ca(2+) release events at baseline. Membrane permeable cAMP analogue (Dioctanoyl-cAMP) triggered subcellular Ca(2+) release events as Ca(2+) sparks and waves. Cells expressing mutant RyR2s showed spontaneous Ca(2+) release events at lower concentrations of cAMP than cells transfected with wild-type RyR2. CONCLUSION: CPVT patients show DADs coinciding with premature action potentials in MAP recordings. Expression studies suggest that DADs are caused by increased propensity of abnormal RyR2s to generate spontaneous Ca(2+) waves in response to cAMP stimulation. Increased sensitivity of mutant RyR2s to cAMP may explain the occurrence of arrhythmias during exercise or emotional stress in CPVT. 相似文献
8.
本实验研究血液与非血液灌流条件下缺血预处理(IP)对心肌的保护作用。应用离体大鼠Langendorf灌流模型,分血液灌流IP组、非血液(KrebsHenseleit液,KH液)灌流IP组及相应的对照组。测量心肌电生理特性等指标。结果与KH液灌流心脏相似,用血液灌流的大鼠心脏经IP后,在随后的停灌和复灌期间,心室颤动阈升高,心律失常发生率明显降低。实验结论为在用血液灌流离体大鼠心脏模型上,IP对心肌的保护作用与用生理溶液灌流的模型基本相同。 相似文献
9.
鱼油抗大鼠实验性心律失常作用 总被引:5,自引:2,他引:3
鱼油口服给药1.4 ml/kg·d,连续15d能显著升高氯化钡致大鼠心律失常的阈剂量(P<0.05),降低心律失常的严重程度(P<0.05),60 min内窦性心率恢复率为85.7%(P<0.01),死亡率为0。心肌细胞膜脂肪酸分析显示,鱼油影响大鼠心肌细胞膜脂肪酸组成,升高DHA含量(P<0.05),降低AA含量及AA/DHA比值(P<0.01)。多元逐步回归分析表明,鱼油的抗心律失常作用与其升高心肌细胞膜DHA含量有关,相关系数为r=-0.5872(P<0.01)。 相似文献
10.
Ramanathan Sundar Varma Shashi Kumar Rao Kolli Madhusudana Muralidharan Srinivasan 《Indian Journal of Thoracic and Cardiovascular Surgery》2004,20(4):164-166
Background Extended trans septal (ETS) approach for mitral valve surgery often divides the artery to the Sino-Atrial node. The clinical
implication of this is contentious. We analyzed our early results with ETS approach.
Methods Between June 1998 and September 2003 eleven patients underwent mitral valve surgery by ETS approach. Six were females. Age
ranged from 19 years to 67 years (median 40 years). Six underwent mitral valve replacement (MVR). Four underwent aortic and
mitral (double) valve replacement (DVR). One had mitral valve repair. Three had additional procedures (tricuspid valve repair=1,
Coronary artery bypass=1, Aorto bifemoral graft=1). Cardiopulmonary bypass ranged from 64 minutes to 77 minutes (median 72
minutes) for MVR and 112 minutes to 178 minutes (median 140 minutes) for DVR. Aortic cross clamp times ranged from 39 minutes
to 52 minutes (median 47 minutes) for MVR and 74 minutes to 120 minutes (median 95 minutes) for DVR.
Results There was no mortality or morbidity attributed to the ETS approach. One early death in emergency DVR was due to heart failure.
Three patients needed seqeuntial pacing in the immediate post-operative period. Nine out of ten survivors were back to their
preoperative rhythms on hospital discharge (6 sinus rhythm; 3 atrial fibrillation). One patient with preoperative trifascicular
block who underwent reoperation to fix a paravalvular mitral leak needed a permanent pacemaker (VVI). The follow-up ranged
from 1 month to 64 months (median 6 months) and is 100% complete. There was no late death or new arrhythmia.
Conclusions Extended trans septal approach is safe. It gives excellent exposure of the mitral valve. division of the sinus node artery
is not deleterious in the short to intermediate term.
Presented at the 50th Annual Meeting of IACTS. New Delhi, Feb. 2004. 相似文献